This inventor holds 1 USPTO granted patent. Top assignee: Chiron Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Lou L Houston: Innovator in Biosynthetic Binding Proteins
Introduction
Lou L Houston is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of biosynthetic binding proteins, particularly in the area of immuno-targeting. Her innovative work has the potential to impact various medical applications, including in vivo imaging and drug targeting.
Latest Patents
Lou L Houston holds a patent for "Biosynthetic binding proteins for immuno-targeting." This patent discloses a formulation designed to target an epitope on an antigen expressed in mammals. The formulation includes a pharmaceutically acceptable carrier along with a dimeric biosynthetic construct that binds to at least one preselected antigen. The construct consists of two polypeptide chains, each defining single-chain Fv (sFv) binding proteins, which have C-terminal tails that facilitate the crosslinking of two sFv polypeptides. The resulting dimeric constructs are designed to bind to the preselected antigen when administered to a mammal, showcasing their utility in medical imaging and drug targeting experiments. Lou L Houston has 1 patent to her name.
Career Highlights
Lou L Houston has worked at Chiron Corporation, where she has been able to apply her expertise in biosynthetic binding proteins. Her role at the company has allowed her to collaborate with other talented professionals in the field, further advancing her research and innovations.
Collaborations
One of her notable coworkers is David B Ring, with whom she has likely shared insights and expertise in their respective areas of research.
Conclusion
Lou L Houston's contributions to the field of biosynthetic binding proteins exemplify her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new applications in immuno-targeting and drug delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
